Recursion Pharmaceuticals Ownership & Insider Activity

Recursion Pharmaceuticals (RXRX) institutional and insider ownership, recent insider transactions and ownership breakdown.

Insiders own 3.1% of shares outstanding. Institutional investors hold 54.5%. Over the past 90 days, insiders made 5 sales worth $466K.

Shares Outstanding

536.271M

Shares Float

511.371M

Insider Shares Owned

16.424M

Insider % Owned

3.1%

Institutional Shares Held

292.041M

Institutional % Held

54.5%

Ownership Breakdown

Net Insider Activity by Month

Purchases (90d)

Sales (90d)

$466K total

Net Activity

Net Selling

Net Value (90d)

-$466K

Recursion Pharmaceuticals Insider Transactions (Last 6 Months)

Date	Insider	Title	Type	Shares	Price	Value
Aug 4, 2026	Blake Borgeson	DIRECTOR	SELL	30.000K	$3.25	$98K
Jul 7, 2026	Blake Borgeson	DIRECTOR	SELL	40.000K	$3.96	$159K
Jun 17, 2026	Namandje Bumpus	DIRECTOR	GRANT	84.461K	$3.18	$13K
Jun 5, 2026	Christopher Gibson	DIRECTOR	SELL-OPTIONS	—	$3.62	$145K
Jun 5, 2026	Najat Khan	CEO AND PRESIDENT	SELL	23.588K	$3.58	$84K
Jun 3, 2026	Namandje Bumpus	DIRECTOR	SELL	4.386K	$3.54	$16K
Jun 2, 2026	Blake Borgeson	DIRECTOR	SELL	30.000K	$3.68	$110K
May 22, 2026	Christopher Gibson	DIRECTOR	SELL-OPTIONS	—	$3.08	$123K
May 7, 2026	Christopher Gibson	DIRECTOR	SELL-OPTIONS	—	$3.37	$135K
May 5, 2026	Blake Borgeson	DIRECTOR	SELL	30.000K	$3.52	$106K
Apr 22, 2026	Christopher Gibson	DIRECTOR	SELL-OPTIONS	—	$3.61	$144K
Apr 7, 2026	Christopher Gibson	DIRECTOR	SELL-OPTIONS	—	$3.10	$124K
Apr 7, 2026	Blake Borgeson	DIRECTOR	SELL	30.000K	$3.10	$93K
Mar 23, 2026	Christopher Gibson	DIRECTOR	SELL-OPTIONS	—	$3.25	$130K
Mar 16, 2026	Ben Taylor	CHIEF FINANCIAL OFFICER	SELL	15.031K	$3.40	$51K
Mar 9, 2026	Najat Khan	CEO AND PRESIDENT	SELL	28.298K	$3.35	$95K
Mar 3, 2026	Blake Borgeson	DIRECTOR	SELL	170.000K	$3.46	$588K